# FDA Inspection 802106 - 21st Century Oncology, Inc. - October 05, 2012

Source: https://www.keypedia.com/records/fda_inspections/21st-century-oncology-inc/87fb1080-ded1-44a0-8374-8ecb4d469817
Source feed: FDA_Inspections

> FDA Inspection 802106 for 21st Century Oncology, Inc. on October 05, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 802106
- Company Name: 21st Century Oncology, Inc.
- Inspection Date: 2012-10-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 684656 - 2010-10-13](https://www.keypedia.com/records/fda_inspections/21st-century-oncology-inc/024222ff-7b6f-4ba8-8625-6eaa9395cee6)
- [FDA Inspection 571143 - 2009-02-13](https://www.keypedia.com/records/fda_inspections/21st-century-oncology-inc/565617c7-f56c-4f4b-8a61-de82bdcc8cae)

Company: https://www.keypedia.com/companies/21st-century-oncology-inc/ea24ac64-ca23-47a8-862e-f53dd6153fad

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d